Stockreport

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion [CNBC]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in vivo CAR-T. In this article Eli Lilly wi [Read more]